Trade Summary

4 days ago, Chadwick Jeremy G, serving as COO at Kymera Therapeutics, Inc. (KYMR), sold 25,758 shares at $83.30 per share, for a total transaction value of $2,145,673.00. Following this transaction, Chadwick Jeremy G now holds 68,052 shares of KYMR.

This sale represents a 27.00% decrease in Chadwick Jeremy G's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, meaning the disclosure happened on the same day as the trade.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.